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S U M M A R Y
Objectives: The aim of this study was to investigate the in vitro and in vivo anti-staphylococcal activity of
a lactic acid bacterial strain and its effect on the intestinal histological damage caused by Staphylococcus
aureus infection.
Methods: Lactobacillus paracasei subsp. paracasei was isolated in our laboratory from breastfed newborn
feces and identiﬁed phenotypically and genotypically. The strain was analyzed by spot-on-lawn and well
diffusion assays for the production of bacteriocins against ﬁve antibiotic-resistant S. aureus strains
isolated from the feces of hospitalized patients with antibiotic-associated diarrhea. The anti-
staphylococcal activity of this strain was evaluated in fermented milk and in vivo using holoxenic
rabbits.
Results: The strain was able to produce a bacteriocin-like substance active against the staphylococcal
strains. A reduction of 2 log in S. aureus cell numbers was registered in co-culture with L. paracasei in
fermented milk. Administration of skimmed milk containing S. aureus (107 cells/ml) to healthy rabbits
induced a persistent diarrheal state 5 days after the challenge. Dissection of the rabbits and consequent
histological observations showed damage and an atrophy of the intestinal and colonic mucosae of the
diarrheal rabbits; in contrast an arrest of the diarrhea concomitant with recovery of the intestinal villi
and the colonic crypts was observed in the rabbits treated with L. paracasei-fermented milk.
Furthermore, the diarrheal state persisted in spite of a decrease in the level of S. aureus cells in the feces of
the rabbits receiving sterile milk; this was in contrast to the rabbits treated with L. paracasei-fermented
milk, in which the decrease in the S. aureus fecal number was associated with the arrest of the diarrhea.
Conclusions: L. paracasei could act as a potential barrier to prevent S. aureus- associated injury and might
exert its effect on the staphylococcal enterotoxins or their target.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Acute infectious diarrhea is a major public health concern
worldwide, particularly in developing countries.1 Antibiotic-
associated diarrhea (AAD) represents a clinical entity leading to
prolonged hospital stays and resulting in additional costs. Most
AAD cases result from a transient disturbance of the function of the
normal intestinal ﬂora. The incidence of AAD varies between 5%
and 25% depending on the antibiotic concerned.2 Staphylococcus
aureus can infect a wide range of host systems, and is responsible
for about 5–20% of nosocomial infections;3 it is recognized as one
of the most frequent causes of AAD. This species was ﬁrst
suspected to cause AAD in 1954.4 Since then several studies
reporting the occurrence of methicillin-resistant S. aureus (MRSA)
in the stools of patients with AAD and also data on speciﬁc toxin* Corresponding author. Tel.: +213 34 21 43 33/35; fax: +213 34 21 47 62.
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doi:10.1016/j.ijid.2011.07.003production have been published.5–7 In two studies, enterotoxin-
producing oxacillin-resistant S. aureus were found as the cause of
nosocomial diarrhea.8,9 S. aureus was ﬁrst recognized as a cause of
enterocolitis in the mid-20th century, and staphylococcal entero-
colitis can occur as a complication of antibiotic therapy. It is a
severe, acute diarrheal illness characterized by pus, blood, and
heavy growth of S. aureus in the stools.10 Early diagnosis and
appropriate therapy can reduce the morbidity of such infections.
In recent decades there has been a growing consumer and
scientiﬁc interest in probiotic bacteria, which are deﬁned as ‘‘live
microorganisms which, when consumed in adequate amounts,
confer a health beneﬁt on the host beyond basic nutrition’’.11
Probiotics play an important role in preventing overgrowth of
potentially pathogenic bacteria and in maintaining the integrity of
the gut mucosal barrier.12 Lactic acid bacteria (LAB), which are
present in large numbers among the normal animal and human
gastrointestinal ﬂora, are some of the most widely-used probiotics
in the fermented food and beverage industries. Lactobacillus casei is
already in use commercially to produce a number of fermentedses. Published by Elsevier Ltd. All rights reserved.
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inhibit bacterial infections when orally administered to mice.13–15
AAD could be prevented through the use of probiotic cultures. In
this study, the beneﬁcial effects of oral administration of probiotic
Lactobacillus paracasei against S. aureus infection were investigated
using young rabbits as an experimental infection model.
2. Materials and methods
2.1. Bacterial strains and growth conditions
L. paracasei subsp. paracasei was used as the probiotic
bacterium. This strain was selected from 38 LAB strains belonging
to Lactobacillus, Lactococcus, Leuconostoc, and Enterococcus species,
on the basis of both its strongest anti-staphylococcal activity and
broadest inhibitory spectrum against 123 strains belonging to
different Gram-positive and Gram-negative pathogenic bacteria
(Listeria monocytogenes, Bacillus cereus, S. aureus, Escherichia coli,
Salmonella enterica, Klebsiella pneumoniae). The strain was classi-
ﬁed at the species level according to its carbohydrate fermentation
pattern using API 50CH strips (BioMe´rieux sa, Marcy l’e´toile,
France), and its identity was further conﬁrmed by sequencing the
gene encoding the 16S rRNA. L. paracasei subsp. paracasei was
grown in de Man–Rogosa–Sharpe (MRS) broth and agar (Merck
GmbH, Darmstadt, Germany) at 37 8C.
As indicator bacteria for the antibacterial activity assay,
antibiotic-resistant S. aureus strains screened in our laboratory were
used. The strains were grown in brain heart infusion broth (BHIB) and
Chapman broth and agar (Difco, Detroit, MI, USA) at 37 8C. For long
term storage, the bacteria were kept at 18 8C in 10% glycerol in their
culture broths. Before the experiments, each bacterial strain was sub-
cultured at least two times (1%, v/v) at 24-h intervals.
2.2. Isolation of S. aureus strains
S. aureus strains included in this study were obtained from
patients at Amizour Hospital, Bejaia, Algeria. Stools from 58 patients
with nosocomial AAD (hospitalization for 72 h) were collected
from December 2008 to March 2009. All samples were investigated
for cultured S. aureus. All stools were cultured aerobically on
Chapman agar (Merck) at 37 8C for 24 h. The bacterial strains were
identiﬁed by typical phenotypic morphology and with the plasma-
coagulase test, and on DNA-agar according to Guiraud and Rosec.16
2.3. Screening of antibiotic-resistant strains of S. aureus
Antimicrobial susceptibility was tested by agar diffusion
method on Mueller–Hinton agar (Bio-Rad-Diagnostic Pasteur,
Marnes la Coquette, France), as recommended by the National
Committee for Clinical Laboratory Standards (NCCLS).17 Interpre-
tation of antimicrobial susceptibility followed the recommenda-
tions of the Antibiogram Committee of the French Microbiology
Society (CA-SFM).18 Nine antibiotics (the most used in the area)
were tested: penicillin G, oxacillin, cefotaxime, cefoxitin, genta-
micin, erythromycin, pristinamycin, vancomycin, and ciproﬂoxa-
cin. All antibiotics were from HiMedia Laboratories Pvt. Ltd.
2.4. Detection of anti-staphylococcal activity
L. paracasei subsp. paracasei was assessed for its ability to
inhibit the antibiotic-resistant S. aureus strains using the spot-on-
lawn and the well diffusion methods, as described previously.19
2.5. Characterization of the antibacterial activity
Filtered supernatant of L. paracasei subsp. paracasei was divided
into three samples. Sample 1 was tested directly; sample 2 wasadjusted to pH 6.5 with 1 N NaOH (Merck-Eurolab, Briare Le Canal,
France) to rule out acid inhibition. Inhibitory activity from the
hydrogen peroxide was ruled out by the addition of catalase (300 U/
ml; C-3515, Sigma–Aldrich Chemie, Steinheim, Germany) to sample
3. The antagonistic activity of the three samples was determined in
duplicate by the well diffusion assay as described above.
The sensitivity of antibacterial compounds to different proteo-
lytic enzymes was tested. The supernatant of the LAB strain was
treated with four proteases (all from Sigma–Aldrich Chemie,
Steinheim, Germany): a-chymotrypsin, proteinase K, trypsin, and
papain. All samples were adjusted to pH 6.5 with 1.0 mol/l NaOH
(Merck), ﬁlter sterilized (0.22-mm pore-size Acrodisc syringe
ﬁlters; Pall Gelman Laboratory, USA), and held for 1 h at 30 8C with
the proteolytic enzymes. The treated and control samples
(supernatant not treated with the enzymes and enzyme prepara-
tions) were heated at 100 8C for 5 min and then immediately
cooled at 4 8C in order to inactivate the enzymes. The heat
treatment of the control samples was performed in order to test
the effect of heat on the bacteriocin-like substance contained in the
supernatant and the effective inactivation of the enzymes. The
residual activity of treated and control samples was determined by
measuring the diameter of the inhibition zones in the well
diffusion assay as described above.
2.6. Measurement of the extracellular potassium (K+) ion
concentration
Overnight cultures of L. paracasei subsp. paracasei strain and
one S. aureus strain (S3) in BHIB were diluted into fresh BHIB (10
8
and 106 cells/ml, respectively) and incubated at 37 8C, both
individually and in co-culture. In the latter case, cultures of L.
paracasei subsp. paracasei (108 cells/ml) were incubated in BHIB
with S. aureus at 106 cells/ml. At intervals (1-h), samples were
removed, centrifuged (8000 g, 20 min, 4 8C), and serially diluted
into sterile distilled water. The appropriate dilutions were
examined for the external concentrations of K+ ions using a ﬂame
photometer (Jenway, Bibby Scientiﬁc France, Nemours, France),
and each treatment was performed in triplicate.
2.7. Antagonism in milk
Overnight cultures of the L. paracasei subsp. paracasei strain and
one S. aureus strain (S3) in BHIB were diluted into fresh sterile
skimmed-milk (market, Bejaia) and incubated at 37 8C, both
individually and in co-culture. In the latter case, cultures of L.
paracasei subsp. paracasei (108 cells/ml) were incubated in sterile
skimmed-milk with S. aureus at 106 cells/ml. At intervals (2-h) over
24 h, samples were removed and serially diluted into sterile saline
solution. The appropriate dilutions were plated on triplicate
Chapman plates, and the average number of colonies obtained
after 24–48 h incubation at 37 8C was used to establish the growth
and survival curves. pH variation (every 2 h) was also monitored
during the incubation period (24 h). The effect of acidiﬁed
skimmed milk (pH values ranging from 5.5 to 4) on the growth
and survival of S. aureus S3 was tested. The pH of milk samples was
adjusted stepwise from 5.5 to 4, in steps of 0.5-pH units, by using
1 M lactic acid (Sigma–Aldrich Chemie, Steinheim, Germany).
Skimmed milk adjusted to pH 4.8 was also included in the test.
2.8. In vivo study – rabbits
All of the experimental rabbits (N = 16) used in this study were
30-day-old rabbits of the same species (Oryctolagus cuniculus)
purchased from a local farm (Bejaia). The rabbits were brooded
under identical conditions (metal cages of 50 cm width, main-
tained in a well-aired ambiance, at constant temperature
Figure 1. Spot test, Lactobacillus paracasei subsp. paracasei against Staphylococcus
aureus S3 with inhibition zone diameter of 20 mm.
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distributed in adapted feeding-bottles. Cages were cleaned every
morning.
2.9. Determination of the staphylococcal intestinal content of rabbits
The 16 rabbits were divided into four groups of four rabbits
each. Before proceeding to the study, a numeration of S. aureus in
the rabbit fecal ﬂora was carried out, and this was undertaken after
3 days of installation in the environment intended for them during
the study period.
2.10. Protocol of inoculation of rabbits with the tested bacteria
Four groups of rabbits were subjected to this study. The
investigation of each experimental group (n = 4) was repeated at
least twice. The rabbits in three of the groups received an oral daily
dose of 5 ml of skimmed milk containing S. aureus S3 (10
7 colony-
forming units (CFU)/ml) for 5 days (until the appearance of the
diarrheal state). Each one of these three groups was then subjected
to a speciﬁc treatment: (1) group 1 (control 1): rabbits did not
receive any treatment; (2) group 2 (control 2): rabbits received an
oral daily dose of 5 ml of sterile skimmed milk for 7 days; (3) group
3: rabbits received an oral daily dose of 5 ml of fermented milk
with L. paracasei subsp. paracasei (2  109 CFU/ml, ﬁnal pH 5.2) for
7 days. In this case, 24 h after the appearance of the persistent
diarrheal state, rabbits were challenged with an L. paracasei subsp.
paracasei strain with a ﬁnal titer of 2  109 CFU/ml. Twenty-four
hours after the L. paracasei subsp. paracasei challenge, the S. aureus
fecal counts were determined. The fermented milk was prepared as
follow: 9 ml of skimmed milk was inoculated with 105 CFU/ml of L.
paracasei subsp. paracasei and then incubated for 18 h at 37 8C.
2.11. Analysis of feces
Feces were recovered before proceeding with the study and
every day at 4 h post-treatment during the study period (12 days),
as follows: during the 5 days of the infection period and the 7 days
of treatment. Five fecal samples from a rabbit were collected in
bottles and analyzed within 6 h. Approximately 5 g was diluted in
45 ml of peptone water (0.1%) and homogenized for 3 min.
Samples were then serially diluted 10-fold using peptone water,
and appropriate dilutions were plated on Chapman agar (Merck).
Plates were incubated aerobically at 37 8C for 48 h.
2.12. Histological examination
In order to study the impact of the S. aureus infection on the
intestinal and colonic mucosae, the rabbits in each group were
dissected at the end of the study. Samples of the small and large
intestine were immediately ﬁxed in 10% neutral-buffered formalin.
Preparation of the microscope slides was conducted according to
Hould20 in an anatomy and cytology–pathology laboratory
(Bejaia). Tissues were dehydrated through graded ethanol series
and acetone, followed by clariﬁcation with xylene, before being
embedded in parafﬁn wax. Several 4-mm thick sections were cut
from each sample and stained with hematoxylin and eosin. Slides
were evaluated using a Zeiss optical microscope.
2.13. Statistical analysis
All results were expressed as mean  standard deviation.
Statistical analysis was performed using the one-way analysis of
variance (ANOVA) procedure of Statistica 5.5 (1999 edition) software.
Differences among means were detected by paired Student’s test.
Values of p < 0.05 were considered statistically signiﬁcant.3. Results
3.1. Isolation and screening of antibiotic-resistant S. aureus strains
Five strains of S. aureus were isolated and identiﬁed from the
feces of patients who suffered from AAD. The ﬁve isolates were
resistant to penicillin G and oxacillin, three were resistant to
cefotaxime, and no resistance was detected for gentamicin,
erythromycin, pristinamycin, vancomycin, and ciproﬂoxacin. All
the strains were sensitive to cefoxitin except strain S3, which was
resistant and consequently resistant to methicillin and to all the
beta-lactams. Strain S3 was selected for the remainder of the study
since it was the only strain possessing resistance to more than
three antibiotics.
3.2. Detection of anti-staphylococcal activity
L. paracasei subsp. paracasei showed inhibition zones on lawns
of S. aureus S3. The inhibition zone diameter was 20 mm (Figure 1).
The antagonistic isolate was also active in the well diffusion assay
(18 mm).
3.3. Characterization of antibacterial activity
The culture supernatant of L. paracasei subsp. paracasei was
characterized for its antibacterial compound. The supernatant
showed an anti-S. aureus activity before (pH 4.2) and after
neutralization (pH 6.5); nevertheless, the inhibition zone (6 mm)
noticed with the neutralized supernatant was smaller than that
with the non-neutralized one (18 mm). Inactivation by catalase
was not observed and an inhibition zone diameter identical to that
of the non-treated supernatant (18 mm) was recorded, which
showed that the antibacterial activity did not result from hydrogen
peroxide. The antibacterial substance produced by the isolate was
completely inactivated by all proteases tested (a-chymotrypsin,
trypsin, proteinase K, and papain). Heat treatment of the super-
natants at 100 8C for 5 min had no effect on the antibacterial
activity.
3.4. K+ leakage measurement
To determine if the L. paracasei subsp. paracasei antibacterial
activity had an effect on the permeabilization of the plasma
membrane of S. aureus cells, expressed as external leakage of K+
Figure 2. Potassium (K+) concentration measurement in the culture supernatants
(Staphylococcus aureus S3 (~), Lactobacillus paracasei (&), S. aureus S3 + L. paracasei
(^).
Figure 4. Evolution of Staphylococcus aureus numbers in rabbit feces during the in
vivo study. ^: group 1, control (rabbits infected with S. aureus but not treated at all
during the experiment); &: group 3, rabbits infected and treated daily with 5 ml of
fermented skimmed milk containing Lactobacillus paracasei subsp. paracasei after
the appearance of the diarrhea.
F. Bendali et al. / International Journal of Infectious Diseases 15 (2011) e787–e794e790ions, the external concentration of this ion was measured in the
culture supernatants of pure and co-cultures conducted in BHIB.
During 4 h of incubation (Figure 2), the concentrations of K+ ions in
the pure culture supernatants of S. aureus S3 and L. paracasei were
unchanged, with values near 40 mg/l. This concentration of K+ ions
measured in pure culture is probably that of the culture medium
(BHIB). In contrast, the concentration of K+ ions in the supernatants
of the co-cultures of L. paracasei with S. aureus S3 was 61.8 mg/l.
Thus, S3 presents important leakage of the cytoplasmic content of
K+ ions in the presence of L. paracasei.
3.5. Co-cultures in skimmed milk
The results reported in Figure 3a show that S. aureus S3 in pure
culture presents a normal growth slope, with an exponential
growth phase from the beginning of the culture. An increase in the
level of cells to 4.5  108 CFU/ml with a decrease in the pH value to
6.1 after 24-h incubation were registered in pure cultures, whereas
in co-cultures, S3 showed a different behavior. During the ﬁrst 4 h
of culture, no signiﬁcant difference was registered between the co-
culture and the control (p > 0.05). The number of S. aureus S3 cells
in co-culture was unchanged between 6 and 20 h (107 CFU/ml),
however growth was very weak compared to the control
(p < 0.05), reaching a value of 4  106 CFU/ml (2 log lesser) after
24 h of culture. The decrease could be explained by the
antagonistic effect of the L. paracasei strain towards S. aureus S3;
this could be the result of synthesis of inhibitory metabolites as
demonstrated in the well diffusion assay. A large decrease in the
pH value of the co-culture (to pH 4.8) compared to that of the pure
culture (to pH 6.1) was registered after 24 h of incubation
(Figure 3b). However this pH value had no inhibitory effect onFigure 3. Growth kinetics of Staphylococcus aureus S3 (a) and pH variation (b) in skimm
Lactobacillus paracasei (106 CFU/ml of S. aureus S3 + 10
8 CFU/ml of L. paracasei) (&).S. aureus S3, since an acidiﬁed skimmed milk adjusted to different
pH values (5.5, 5, 4.8, and 4.5) was tested against the strain and no
inhibitory effect was observed at pH 4.5 or 4.8.
3.6. In vivo study
The in vivo study was undertaken using holoxenic rabbits, so it
was important to estimate the staphylococcal cell number in the
rabbit feces before the beginning of the S. aureus S3 infection
procedure. After numeration, a mean of 2 log (102 cells of
staphylococci/g of feces) was registered. The infection of rabbits
(three groups) with a daily dose of 5 ml of fermented milk
containing 107 CFU/ml of S. aureus resulted in diarrhea from the 5th
day in all of the rabbits. During these 5 days, the S. aureus cell
number increased from 102 to 1.7  108 CFU/g of feces (Figure 4),
with no signiﬁcant difference (p > 0.05) among the three groups.
However, the diarrhea did not appear immediately after the
administration of S. aureus S3 (10
7 CFU/ml); this was probably due
to the destruction of a large part of the strain cells before reaching
the intestinal and colonic mucosae. This decrease in number could
have been the result of a gastric acidity effect and the action of bile
salts, or a barrier effect exerted by the indigenous intestinal
microﬂora. The number of S. aureus reaching the intestine (neutral
pH) will increase as a consequence of the adhesion and the
multiplication of the strain. Furthermore, the daily administration
of the contaminated milk probably allowed the increase in number
of enteric S. aureus until it reached the infectious dose and
consequently the minimal threshold concentration of enterotoxins
necessary to induce diarrhea.ed milk, in pure cultures (S. aureus S3 at 10
6 CFU/ml) (^) and in co-cultures with
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From the appearance of persistent diarrhea (day 5), the rabbits
in group 2 received 5 ml of sterile skimmed milk daily, and those of
group 3 received a daily dose of 5 ml of the same milk fermented by
L. paracasei (2  109 CFU/ml), for 7 days. In the case of the rabbits in
group 1 (untreated), the diarrhea persisted for 4 days after the
arrest of the infection. During this period, the health state of the
rabbits deteriorated (decrease in feeding, behavior changes). At the
end of this period, it was noticed that the feces became softer, and
the S. aureus number in the feces decreased from 1.7  108 to
1.7  106 CFU/g (p < 0.05) by the end of the experiment (day 12)
(Figure 4). In the case of the treated rabbits (group 3), the number
of S. aureus cells decreased at 24-h post-treatment. This decrease
became signiﬁcant (1.7 log; 1.58  108 to 3.5  106 CFU/g) after
48 h (p < 0.05) compared to rabbits in group 1. At the end of this
period, the diarrhea disappeared and the sanitary status of the
rabbits was improved with a less soft feces. At day 7 of treatment,
the feces counts of S. aureus of the rabbits in group 3 diminishedFigure 5. Histological observations of intestinal sections of dissected rabbits (8  40  5)
diarrhea). (c) Untreated diarrheal rabbit receiving sterile skimmed milk (group 2). (d) Tre
(group 3).signiﬁcantly (2  104 CFU/g) and seemed to return to the initial
value (102 CFU/g) and were signiﬁcantly (p < 0.05) lower than
those in group 2 (2  106 CFU/g). This difference can be explained
by the fact that rabbits in group 3 received milk fermented by L.
paracasei and those in group 2 were fed only skimmed sterile milk.
The results obtained at the end of this study show the beneﬁcial
effect of milk fermented by L. paracasei towards S. aureus diarrhea.
3.8. Histological observations
The lesions caused by S. aureus involve both the small intestine
and colon. The histopathological evaluation of intestinal and colon
tissue sections is shown in Figures 5 and 6. Intestinal and colon
sections from rabbits challenged with S. aureus (Figures 5b and 6b)
showed a high degree of intestinal and colonic injury, with
pathological characteristics including severe loss of the mucosa
and damage to the intestinal villi and colonic crypts, resulting in
abnormal intestinal and colon wall morphology and the loss of
intestinal and colonic structural integrity. In contrast, intestinal. (a) Healthy rabbit (control). (b) Diarrheal rabbit (group 1, ﬁrst day of appearance of
ated diarrheal rabbit receiving skimmed milk fermented with Lactobacillus paracasei
Figure 6. Histological observations of colon sections of dissected rabbits (8  40  5). (a) Healthy rabbit (control). (b) Diarrheal rabbit (group 1, ﬁrst day of appearance of
diarrhea). (c) Untreated diarrheal rabbit receiving sterile skimmed milk (group 2). (d) Treated diarrheal rabbit receiving skimmed milk fermented with L. paracasei (group 3).
Figure 7. Granulocyte inﬁltration into the intestinal mucosa of diarrheal rabbits
infected with a strain of Staphylococcus aureus.
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and 6a) presented intact structures. As shown in Figures 5d and 6d,
rabbits treated with L. paracasei after S. aureus infection also
showed intact intestine and colon, with complete intestinal and
colonic mucosae and restructured villi and crypts, which were
compact and relatively long when compared with those of
skimmed sterile milk-treated rabbits (Figure 5c and 6c). The
integrity of the intestinal villi and the colonic crypts is considered
an important criterion that reﬂects the degree of intestinal and
colonic injury. As shown in Figures 5b and 6b, the villi and crypts of
rabbits of the S. aureus-infected control group were signiﬁcantly
different from the normal villi and crypts of the unchallenged
rabbits (Figures 5a and 6a). The villi and crypts of rabbits treated
with L. paracasei were recovered compared to those of the S.
aureus-infected control group. As reported by Chen et al.21,
intestinal pathological determination depends on the following
criteria: intestinal and villous structural integrity, intestinal tissue
bleeding, blood vessel dilation, intestinal villous morphology, loss
of goblet cells, mucosal damage, intestinal crypt damage, and
degree of inﬂammation. Rabbits treated with L. paracasei possessedrestructured villi, whereas rabbits from the other two experimen-
tal groups – those receiving skimmed sterile milk and those
receiving S. aureus only – had signiﬁcantly destroyed villi
compared to the unchallenged control group (Figures 5 and 6).
Furthermore, histological observations of the intestinal and colon
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showed the presence of granulocytes at the site of infection.
Figure 7 illustrates an example of an inﬂammatory reaction at the
intestinal mucosa of a diarrheal rabbit.
4. Discussion
Staphylococcus aureus has acquired different types of resistance
to anti-staphylococcal agents. Nowadays, 80% to 95% of hospital-
associated S. aureus strains produce a penicillinase that inhibits the
majority of penicillins.22 In this study S. aureus was isolated from
stool samples of patients with diarrhea who were hospitalized for
72 h at Amizour Hospital in Bejaia, Algeria. S. aureus was isolated
from ﬁve (8.6%) of the fecal samples. All ﬁve S. aureus strains were
identiﬁed as penicillin G- and oxacillin-resistant, three were
resistant to cefotaxime, and only one strain (S3) was resistant to
cefoxitin and consequently resistant to methicillin and to all the
beta-lactams. In the study of Flemming and Ackermann23 that
included 71 patients with S. aureus-positive stool samples, data on
antimicrobial therapy showed that 18.3% of the patients had been
treated with penicillins, and out of 198 S. aureus-positive stools,
14.6% of S. aureus strains were identiﬁed as methicillin-resistant. In
another study, Baba-Moussa et al.24 observed that among 21 S.
aureus strains from patients with post-AAD, all strains harbored
resistance to penicillin G and 95% to oxacillin/methicillin.
However, despite the emergence of penicillin resistance, the
antibiotic is still being used to treat staphylococcal infections, and
despite the recognition of post-antibiotic S. aureus-associated
diarrhea, treatment of infectious diseases is still based on antibiotic
prescription.
Since most AAD cases result from a transient disturbance in the
function of the normal intestinal ﬂora, the use of certain probiotics,
mainly LAB, could accelerate the reestablishment of the indigenous
microﬂora and reduce adhesion and viability of adherent S. aureus.
Indeed LAB, one of the groups of probiotics, make up a large group
of microorganisms in the gastrointestinal tract of all humans and
animals. The basic requirements for a LAB strain which is to be
used as a probiotic have been described. It should be tolerant to
acid and bile and be able to: adhere to the intestinal epithelium of
the host; show an antagonistic activity against pathogenic
bacteria; and retain its viability during processing and storage.25
The strain used in this study (L. paracasei subsp. paracasei) has
already been demonstrated to fulﬁll these criteria; it was able to
adhere to Caco-2 cells and to prevent the adhesion of entero-
pathogenic E. coli (EPEC) and Salmonella Typhimurium, and was
also able to overcome simulated gastrointestinal conditions (paper
submitted for publication). In this study we demonstrated that this
strain is able to produce an antibacterial substance sensitive to
proteases; consequently, this strongly suggests that this substance
is proteinaceous in nature and can be designated as a bacteriocin-
like substance. Furthermore the antibacterial activity was directed
towards the plasma membrane, as shown by the leakage of K+ ions,
and this is a characteristic of bacteriocins, which target the plasma
membrane of the sensitive strains.26 Moreover, in another study
(in progress), treatment of L. paracasei culture supernatant with
either proteases or heat (80 8C for 2 h) affects its activities, and
puriﬁcation trials using Sepack cartridges and ion exchange
chromatography procedures indicate, respectively, a high hydro-
phobicity and a cationic nature of the active substance (data not
shown here). Nevertheless, further experiments are necessary to
identify the chemical nature of the antibacterial compounds.
On the basis of the in vitro results, the L. paracasei subsp.
paracasei strain can be used as a probiotic. In order to evaluate its
beneﬁts in the case of an S. aureus infection, an in vivo study was
carried out. Since staphylococcal enterotoxins primarily affect
primates, we used rabbits as the animal model for the study of theS. aureus intestinal infection. Due to the use of holoxenic rabbits, an
estimation of the normal S. aureus intestinal level before
contamination was mandatory, and the results indicate a level
of 2 log. This level has already been described in healthy subjects as
a part of the normal commensal microﬂora, as stated by Simonova
et al.27 who found that the total counts of staphylococci in the feces
of rabbits varied from 1.00 to 1.79 log CFU/g. Administration of
skimmed milk containing S. aureus (107 cells/ml) to healthy rabbits
induced a persistent diarrheal state at 5 days after the challenge.
Histopathological observations showed destruction of the micro-
villi and colonic crypts, with granulocyte inﬁltration. According to
Lin et al.10 common features of S. aureus enterocolitis are acute
inﬂammation and epithelial cell damage with disruption of the
usual architecture. Biopsies of the ileum and colon have
demonstrated superﬁcial acute inﬂammation, mild chronic in-
ﬂammation with increased eosinophils in the lamina propria, and
basal plasmacytosis in the colon.10 These alterations are probably
the result of S. aureus toxins. Indeed this species can produce a
wide variety of toxins, including the toxic shock syndrome toxin
(TSST-1), enterotoxins, and the enterotoxin-like proteins that can
function as superantigens, with both local and systemic effects.28
Several enterotoxins have been detected in strains associated with
AAD. In the study of Flemming and Ackermann,23 114 S. aureus
strains produced enterotoxins in vitro. Interestingly, an arrest of
the diarrhea concomitant with recovery of the intestinal villi and
the colonic crypts was observed in the rabbits treated with L.
paracasei-fermented milk. Probiotics, including lactobacilli, are
known to produce organic acids such as lactic acid, which possess
potent bactericidal activity.21 Production of lactic acid, the major
metabolite of LAB, is responsible for the associated decrease in pH,
which may be sufﬁcient to antagonize many microorganisms.
However in this study, the pH value of the fermented milk
administered to rabbits was not active against the strain of S.
aureus tested. Consequently the inhibitory effect observed on S.
aureus cells could be due to the action of the L. paracasei cells or
their metabolites.
Our results are in agreement with those of Vesterlund et al.29
who reported that in displacement in vitro assays, the amount of
adherent S. aureus in human intestinal mucus was reduced 44% by
Lactobacillus rhamnosus GG and 41% by Lactococcus lactis subsp.
lactis, and that adherent probiotics reduced the viability of
adherent S. aureus by 27–36%, depending on the strain, within
2 h. However in our study, the action of the L. paracasei subsp.
paracasei appeared to be directed towards the staphylococcal
toxins rather than the cells, since the diarrheal state persisted in
spite of a decrease in the S. aureus cell level in the feces of the
rabbits receiving sterile milk, in contrast to the rabbits treated with
L. paracasei-fermented milk, in which the decrease in the S. aureus
fecal number was associated with the arrest of the diarrhea.
Indeed, treatment with the sterile milk induced a decrease in the S.
aureus number in the feces (day 12); this is probably due to the
arrest of the infection, but also to the intestinal microﬂora effect
which prevents the adhesion of S. aureus (‘barrier effect’), gastric
pH, and bile salts. However, the persistence of the diarrhea could
be explained by the presence of S. aureus enterotoxins which
continued to act in the gastrointestinal tract of rabbits and induced
diarrhea.
Thus, the strain of L. paracasei could be used as a potential
barrier to prevent infection or as treatment of enteric staphylo-
coccal infection, and might exert its effect on the S. aureus toxins or
their target, probably by production of bacteriocin-like substances,
which might contribute to the antibacterial effect in vivo. In our
study we demonstrated that administration of milk containing L.
paracasei subsp. paracasei to rabbits infected by multidrug-
resistant S. aureus arrests the diarrhea and improves the
reestablishment of the intestinal and colonic mucosae.
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